Our subsequent results further determined this hypothesis, evidenced by that the inhibition of RKIP by locostatin weakened the relieving effects of DNM on the allergic inflammatory response, oxidative stress, and pathological injury in asthma mice. The gene discussed is PEBP1; the disease is asthma.